206 related articles for article (PubMed ID: 16026311)
1. CB1 and CB2 cannabinoid receptor binding studies based on modeling and mutagenesis approaches.
Ortega-Gutiérrez S; López-Rodríguez ML
Mini Rev Med Chem; 2005 Jul; 5(7):651-8. PubMed ID: 16026311
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.
Ashton JC; Wright JL; McPartland JM; Tyndall JD
Curr Med Chem; 2008; 15(14):1428-43. PubMed ID: 18537620
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptors and their ligands: ligand-ligand and ligand-receptor modeling approaches.
Reggio PH
Handb Exp Pharmacol; 2005; (168):247-81. PubMed ID: 16596777
[TBL] [Abstract][Full Text] [Related]
4. Preface.
Methods Enzymol; 2017; 593():xvii-xxiv. PubMed ID: 28750818
[No Abstract] [Full Text] [Related]
5. C3-heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor.
Dixon DD; Tius MA; Thakur GA; Zhou H; Bowman AL; Shukla VG; Peng Y; Makriyannis A
Bioorg Med Chem Lett; 2012 Aug; 22(16):5322-5. PubMed ID: 22796181
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and testing of novel classical cannabinoids: exploring the side chain ligand binding pocket of the CB1 and CB2 receptors.
Nadipuram AK; Krishnamurthy M; Ferreira AM; Li W; Moore BM
Bioorg Med Chem; 2003 Jul; 11(14):3121-32. PubMed ID: 12818675
[TBL] [Abstract][Full Text] [Related]
7. Prediction of the Binding Affinities and Selectivity for CB1 and CB2 Ligands Using Homology Modeling, Molecular Docking, Molecular Dynamics Simulations, and MM-PBSA Binding Free Energy Calculations.
Ji B; Liu S; He X; Man VH; Xie XQ; Wang J
ACS Chem Neurosci; 2020 Apr; 11(8):1139-1158. PubMed ID: 32196303
[TBL] [Abstract][Full Text] [Related]
8. Highly Selective, Amine-Derived Cannabinoid Receptor 2 Probes.
Westphal MV; Sarott RC; Zirwes EA; Osterwald A; Guba W; Ullmer C; Grether U; Carreira EM
Chemistry; 2020 Jan; 26(6):1380-1387. PubMed ID: 31961047
[TBL] [Abstract][Full Text] [Related]
9. Discovery and functional evaluation of diverse novel human CB(1) receptor ligands.
Foloppe N; Benwell K; Brooks TD; Kennett G; Knight AR; Misra A; Monck NJ
Bioorg Med Chem Lett; 2009 Aug; 19(15):4183-90. PubMed ID: 19520572
[TBL] [Abstract][Full Text] [Related]
10. Indoles and related compounds as cannabinoid ligands.
Manera C; Tuccinardi T; Martinelli A
Mini Rev Med Chem; 2008 Apr; 8(4):370-87. PubMed ID: 18473928
[TBL] [Abstract][Full Text] [Related]
11. Targeting the cannabinoid CB2 receptor: mutations, modeling and development of CB2 selective ligands.
Raitio KH; Salo OM; Nevalainen T; Poso A; Järvinen T
Curr Med Chem; 2005; 12(10):1217-37. PubMed ID: 15892633
[TBL] [Abstract][Full Text] [Related]
12. Molecular biology of cannabinoid receptors.
Abood ME
Handb Exp Pharmacol; 2005; (168):81-115. PubMed ID: 16596772
[TBL] [Abstract][Full Text] [Related]
13. Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB
Aviz-Amador A; Contreras-Puentes N; Mercado-Camargo J
Comput Biol Chem; 2021 Dec; 95():107590. PubMed ID: 34700256
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid CB2/CB1 selectivity. Receptor modeling and automated docking analysis.
Tuccinardi T; Ferrarini PL; Manera C; Ortore G; Saccomanni G; Martinelli A
J Med Chem; 2006 Feb; 49(3):984-94. PubMed ID: 16451064
[TBL] [Abstract][Full Text] [Related]
15. Crystal Structure of the Human Cannabinoid Receptor CB2.
Li X; Hua T; Vemuri K; Ho JH; Wu Y; Wu L; Popov P; Benchama O; Zvonok N; Locke K; Qu L; Han GW; Iyer MR; Cinar R; Coffey NJ; Wang J; Wu M; Katritch V; Zhao S; Kunos G; Bohn LM; Makriyannis A; Stevens RC; Liu ZJ
Cell; 2019 Jan; 176(3):459-467.e13. PubMed ID: 30639103
[TBL] [Abstract][Full Text] [Related]
16. The effects of charge-neutralizing mutation D6.30N on the functions of CB1 and CB2 cannabinoid receptors.
Nebane NM; Kellie B; Song ZH
FEBS Lett; 2006 Oct; 580(22):5392-8. PubMed ID: 16989818
[TBL] [Abstract][Full Text] [Related]
17. Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-G
Hua T; Li X; Wu L; Iliopoulos-Tsoutsouvas C; Wang Y; Wu M; Shen L; Brust CA; Nikas SP; Song F; Song X; Yuan S; Sun Q; Wu Y; Jiang S; Grim TW; Benchama O; Stahl EL; Zvonok N; Zhao S; Bohn LM; Makriyannis A; Liu ZJ
Cell; 2020 Feb; 180(4):655-665.e18. PubMed ID: 32004463
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
Rao GK; Kaminski NE
J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496
[TBL] [Abstract][Full Text] [Related]
19. Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB
Asproni B; Murineddu G; Corona P; Pinna GA
Molecules; 2021 Apr; 26(8):. PubMed ID: 33917187
[TBL] [Abstract][Full Text] [Related]
20. Ligand-binding architecture of human CB2 cannabinoid receptor: evidence for receptor subtype-specific binding motif and modeling GPCR activation.
Pei Y; Mercier RW; Anday JK; Thakur GA; Zvonok AM; Hurst D; Reggio PH; Janero DR; Makriyannis A
Chem Biol; 2008 Nov; 15(11):1207-19. PubMed ID: 19022181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
